User profiles for Darren K. McGuire
 | Darren K. McGuireDistinguished Teaching Professor of Medicine; University of Texas Southwestern Medical … Verified email at utsouthwestern.edu Cited by 184231 |
Heart disease and stroke statistics—2016 update: a report from the American Heart Association
…, S Liu, RH Mackey, DJ Magid, DK McGuire… - circulation, 2016 - Am Heart Assoc
Each year, the American Heart Association (AHA), in conjunction with the Centers for Disease
Control and Prevention, the National Institutes of Health, and other government agencies, …
Control and Prevention, the National Institutes of Health, and other government agencies, …
Heart disease and stroke statistics—2015 update: a report from the American Heart Association
Each year, the American Heart Association (AHA), in conjunction with the Centers for Disease
Control and Prevention, the National Institutes of Health, and other government agencies, …
Control and Prevention, the National Institutes of Health, and other government agencies, …
Heart disease and stroke statistics—2014 update: a report from the American Heart Association
…, GM Marcus, A Marelli, DB Matchar, DK McGuire… - circulation, 2014 - Am Heart Assoc
Each year, the American Heart Association (AHA), in conjunction with the Centers for Disease
Control and Prevention, the National Institutes of Health, and other government agencies, …
Control and Prevention, the National Institutes of Health, and other government agencies, …
Heart disease and stroke statistics—2013 update: a report from the American Heart Association
…, GM Marcus, A Marelli, DB Matchar, DK McGuire… - Circulation, 2013 - Am Heart Assoc
Each year, the American Heart Association (AHA), in conjunction with the Centers for Disease
Control and Prevention, the National Institutes of Health, and other government agencies, …
Control and Prevention, the National Institutes of Health, and other government agencies, …
[HTML][HTML] Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus
…, NR Desai, O Mosenzon, DK McGuire… - … England Journal of …, 2013 - Mass Medical Soc
Background The cardiovascular safety and efficacy of many current antihyperglycemic agents,
including saxagliptin, a dipeptidyl peptidase 4 (DPP-4) inhibitor, are unclear. Methods We …
including saxagliptin, a dipeptidyl peptidase 4 (DPP-4) inhibitor, are unclear. Methods We …
[HTML][HTML] Dapagliflozin and cardiovascular outcomes in type 2 diabetes
Background The cardiovascular safety profile of dapagliflozin, a selective inhibitor of sodium–glucose
cotransporter 2 that promotes glucosuria in patients with type 2 diabetes, is …
cotransporter 2 that promotes glucosuria in patients with type 2 diabetes, is …
[HTML][HTML] Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes
…, J Koglin, S Korn, JM Lachin, DK McGuire… - … England Journal of …, 2015 - Mass Medical Soc
Background Data are lacking on the long-term effect on cardiovascular events of adding
sitagliptin, a dipeptidyl peptidase 4 inhibitor, to usual care in patients with type 2 diabetes and …
sitagliptin, a dipeptidyl peptidase 4 inhibitor, to usual care in patients with type 2 diabetes and …
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of …
Background The magnitude of effect of sodium-glucose cotransporter-2 inhibitors (SGLT2i)
on specific cardiovascular and renal outcomes and whether heterogeneity is based on key …
on specific cardiovascular and renal outcomes and whether heterogeneity is based on key …
B-type natriuretic peptide in cardiovascular disease
Natriuretic peptide hormones, a family of vasoactive peptides with many favourable physiological
properties, have emerged as important candidates for development of diagnostic tools …
properties, have emerged as important candidates for development of diagnostic tools …
Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: a meta-analysis
DK McGuire, WJ Shih, F Cosentino… - JAMA …, 2021 - jamanetwork.com
Importance Sodium-glucose cotransporter 2 (SGLT2) inhibitors favorably affect cardiovascular
(CV) and kidney outcomes; however, the consistency of outcomes across the class …
(CV) and kidney outcomes; however, the consistency of outcomes across the class …